- Home
- IRON vs NX Comparison
IRON vs NX Comparison
Compare IRON & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- NX
- Stock Information
- Founded
- IRON 2017
- NX 1927
- Country
- IRON United States
- NX United States
- Employees
- IRON N/A
- NX N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- NX Metal Fabrications
- Sector
- IRON Health Care
- NX Industrials
- Exchange
- IRON Nasdaq
- NX Nasdaq
- Market Cap
- IRON 1.4B
- NX 1.4B
- IPO Year
- IRON N/A
- NX N/A
- Fundamental
- Price
- IRON $59.46
- NX $29.94
- Analyst Decision
- IRON Strong Buy
- NX Strong Buy
- Analyst Count
- IRON 10
- NX 1
- Target Price
- IRON $72.00
- NX $38.00
- AVG Volume (30 Days)
- IRON 431.6K
- NX 317.1K
- Earning Date
- IRON 11-12-2024
- NX 12-12-2024
- Dividend Yield
- IRON N/A
- NX 1.07%
- EPS Growth
- IRON N/A
- NX N/A
- EPS
- IRON N/A
- NX 2.25
- Revenue
- IRON N/A
- NX $1,081,193,000.00
- Revenue This Year
- IRON N/A
- NX $16.40
- Revenue Next Year
- IRON N/A
- NX $49.16
- P/E Ratio
- IRON N/A
- NX $13.31
- Revenue Growth
- IRON N/A
- NX N/A
- 52 Week Low
- IRON $25.60
- NX $24.85
- 52 Week High
- IRON $77.60
- NX $39.31
- Technical
- Relative Strength Index (RSI)
- IRON 58.39
- NX 51.80
- Support Level
- IRON $63.21
- NX $30.30
- Resistance Level
- IRON $68.73
- NX $31.00
- Average True Range (ATR)
- IRON 3.49
- NX 0.76
- MACD
- IRON 0.52
- NX -0.03
- Stochastic Oscillator
- IRON 61.25
- NX 49.19
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its three operating segments are North American Fenestration being the key revenue driver, European Fenestration, and North American Cabinet Components. Geographically, it derives a majority of revenue from the United States.